Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2

J Clin Invest. 2020 Sep 1;130(9):5027. doi: 10.1172/JCI142404.
No abstract available

Publication types

  • Expression of Concern